SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-005433
Filing Date
2021-03-09
Accepted
2021-03-09 17:16:03
Documents
13
Period of Report
2021-03-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20210309_8k.htm   iXBRL 8-K 36542
  Complete submission text file 0001437749-21-005433.txt   169774

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acrx-20210303.xsd EX-101.SCH 3699
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20210303_def.xml EX-101.DEF 11585
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20210303_lab.xml EX-101.LAB 15465
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20210303_pre.xml EX-101.PRE 11739
6 EXTRACTED XBRL INSTANCE DOCUMENT acrx20210309_8k_htm.xml XML 2565
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 21726903
SIC: 2834 Pharmaceutical Preparations